Company Valuation: Integra LifeSciences Holdings Corporation

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 5,674 4,683 3,405 1,750 967.4 1,222 - -
Change - -17.47% -27.3% -48.6% -44.72% 26.3% - -
Enterprise Value (EV) 1 6,707 5,670 4,605 3,285 2,563 2,711 2,507 2,286
Change - -15.47% -18.78% -28.66% -21.98% 5.78% -7.54% -8.79%
P/E 33.8x 26x 51.8x -252x -1.84x 24.5x 12.6x 9.67x
PBR 3.37x 2.6x 2.14x 1.13x 0.93x 1.05x 0.93x 0.83x
PEG - 2.86x -0.8x 2x -0x -0x 0.1x 0.3x
Capitalization / Revenue 3.68x 3.01x 2.21x 1.09x 0.59x 0.73x 0.71x 0.68x
EV / Revenue 4.35x 3.64x 2.99x 2.04x 1.57x 1.62x 1.45x 1.28x
EV / EBITDA 16.7x 13.8x 12.5x 10.2x 8.07x 7.87x 6.91x 5.92x
EV / EBIT 21.4x 15.5x 14x 11.7x 9.33x 9.11x 7.93x 6.8x
EV / FCF 25.4x 25.5x 63x 132x -82.5x 11.8x 18.2x 14.8x
FCF Yield 3.94% 3.92% 1.59% 0.76% -1.21% 8.44% 5.5% 6.76%
Dividend per Share 2 - - - - - - - -
Rate of return - - - - - - - -
EPS 2 1.98 2.16 0.84 -0.09 -6.74 0.64 1.245 1.625
Distribution rate - - - - - - - -
Net sales 1 1,542 1,558 1,542 1,611 1,635 1,674 1,728 1,786
EBITDA 1 400.7 411.3 369.7 322.2 317.5 344.3 363 385.9
EBIT 1 314.1 366.6 329.1 281.1 274.8 297.6 315.9 336.3
Net income 1 169.1 180.6 67.74 -6.944 -516.5 42.03 78.69 100.4
Net Debt 1 1,033 986.7 1,200 1,535 1,596 1,489 1,285 1,064
Reference price 2 66.99 56.07 43.55 22.68 12.42 15.71 15.71 15.71
Nbr of stocks (in thousands) 84,700 83,518 78,176 77,164 77,892 77,773 - -
Announcement Date 23/02/22 22/02/23 28/02/24 25/02/25 26/02/26 - - -
1USD in Million2USD
Estimates

P/E, Detailed evolution



P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
24.55x1.62x7.87x-.--% 1.22B
29.21x4.03x15.58x2.49% 178B
19.84x3.61x12.91x3% 120B
17.86x0.21x13.03x0.73% 62.25B
27.51x6.75x17.39x1.45% 48.54B
35.25x3.41x11.68x2.15% 49.82B
33.94x5.96x18.72x-.--% 31.95B
42.07x1.24x11.48x0.22% 28.59B
41.42x7.26x26.04x0.25% 25B
16.86x2.69x9.53x1.64% 21.59B
Average 28.85x 3.68x 14.42x 1.19% 56.73B
Weighted average by Cap. 27.34x 3.76x 14.73x 1.9%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA



Year-on-year evolution of the Yield

  1. Stock Market
  2. Stocks
  3. IART Stock
  4. Valuation Integra LifeSciences Holdings Corporation
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!